publication date: Sep. 5, 2014


html Tobacco.html

Health Groups Urge FDA To Regulate Tobacco Products


The American Association for Cancer Research and the American Society of Clinical Oncology urged the FDA to regulate all tobacco products, including e-cigarettes.

Additionally, 24 public health and medical organizations filed public comments in response to an FDA proposal to extend its regulatory authority over tobacco products.

Specifically, AACR and ASCO called for banning youth-oriented advertising and marketing, self-service product displays, and tobacco company sponsorship of youth-oriented events, in addition to restricting sales to minors and implementing age-verification procedures for internet sales. All the organizations expressed concern about the proliferation of flavored e-cigarettes.

“We believe it is vitally important for the FDA to begin regulating these products, especially because we don’t know much about the health effects of e-cigarette use,” said ASCO President Peter Yu. “We are also quite concerned that e-cigarettes may increase the likelihood that nonsmokers or former smokers will use combustible tobacco products or that they will discourage smokers from quitting.”

Roy Herbst, chair of the AACR Tobacco and Cancer Subcommittee, said, “There are insufficient data on the long-term health consequences of e-cigarettes, their value as tobacco cessation aids, or their effects on the use of conventional cigarettes,” Herbst is chief of medical oncology at Yale Comprehensive Cancer Center. “Any benefits of e-cigarettes are most likely to be realized in a regulated environment in which appropriate safeguards can be implemented.”

AACR and ASCO encouraged the agency to ban e-cigarette flavors or flavor names that are brand names of candy, cookies, soda, and other such products, and to prohibit e-cigarettes containing candy and other youth-friendly flavors, unless there is evidence demonstrating that they do not … Continue reading 40-33 Tobacco

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.